Our CEO Paul Brennan has just returned from the US after two weeks meeting with our US sales team, many hospitals and their surgeons. We received an overwhelming positive response to our NovoSorb™ BTM and to the underlying benefits it brings for patients and the hospitals.
it's looking good! PNV is going to sky rocket within 2 years - share price $5.00 and paying fully franked dividends Good luck to all!
Ann: Business update and earnings guidance, page-2
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.61 |
Change
0.020(0.77%) |
Mkt cap ! $1.801B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.62 | $2.56 | $2.442M | 940.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6098 | $2.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.62 | 193477 | 8 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |